Medplus Health Services Ltd
Pharmaceuticals & Biotechnology | Small Cap
Medplus Health Services Ltd demonstrates a mixed financial performance. The company shows strong growth and profitability, supported by solid solvency and liquidity. Growth is fueled by impressive revenue and earnings per share increases. Profitability metrics such as return on assets and gross profit margin also indicate healthy financial performance. Solvency ratios suggest a stable financial structure. However, efficiency and coverage ratios reveal some areas of concern. Capital expenditure management and dividend policies need attention. The company's liquidity position is strong with good current and cash ratios. Overall, Medplus exhibits sound financial health, but needs to address certain operational inefficiencies and coverage weaknesses to sustain long-term growth and stability. The company's robust performance in growth and profitability is a positive sign for future prospects.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio5.60
- Profitability Ratio10.00
- Efficiency Ratio5.33
- Coverage Ratio4.40
- Solvency Ratio8.40
- Liquidity Ratio8.10
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBearish
- 2 HoursBearish
- 4 HoursBearish
- 1 DayBearish
- 1 WeekBullish
- 1 MonthBullish
Medplus Health Services Ltd demonstrates a mixed financial performance. The company shows strong growth and profitability, supported by solid solvency and liquidity. Growth is fueled by impressive revenue and earnings per share increases. Profitability metrics such as return on assets and gross profit margin also indicate healthy financial performance. Solvency ratios suggest a stable financial structure. However, efficiency and coverage ratios reveal some areas of concern. Capital expenditure management and dividend policies need attention. The company's liquidity position is strong with good current and cash ratios. Overall, Medplus exhibits sound financial health, but needs to address certain operational inefficiencies and coverage weaknesses to sustain long-term growth and stability. The company's robust performance in growth and profitability is a positive sign for future prospects.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
165.89
Industry Median
47.76
Small Cap Median
47.76
P/E RATIO
47.14
P/B RATIO
5.23
Industry Median
5.13
Small Cap Median
5.13
P/S RATIO
1.46
Industry Median
4.57
Small Cap Median
4.57
Others
PEG RATIO
1.66
EV/EBITDA RATIO
16.29
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹862.65 as on Jun 17, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Concall Report⬤4th Feb 26
Q3 FY26 Earnings Conference Call
BULLISH SENTIMENT
Medplus Health Services demonstrates strong growth across various metrics. High revenue, operating profit, EPS, asset, and net income growth rates indicate robust expansion. This consistent growth reflects effective strategies and market positioning. The company's growth trajectory positions it favorably for future success and market leadership. The company should maintain its effective strategies and market positioning to maintain its growth.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 23.13 | 20.61 | 23.41 | 9.08 | 12.32 |
| Operating Profit Growth Rate | 25.81 | -2.56 | 33.46 | 37.46 | 24.39 |
| Earnings Per Share (EPS) Growth | -99.42 | -48.07 | 31.41 | 129.2 | 45.7 |
| Asset Growth Rate | 65.64 | 7.83 | 7.44 | 11.81 | 17.05 |
| Net Income Growth Rate | 50.79 | -47.37 | 32 | 127.27 | 46.67 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Medplus Health Services exhibits mixed financial performance. While cash earnings per share and book value per share are strong, adjusted earnings per share is average. Dividend payouts and capital expenditure management need improvement. Effective cash earnings and strong book value per share are key strengths, but the company should focus on enhancing adjusted earnings and optimizing capital expenditures.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 7.58 | 4 | 5.25 | 12.17 | 18.33 |
| Cash Earnings Per Share (Cash EPS) | 17.83 | 19.33 | 24.17 | 33.33 | 41.92 |
| Book Value Per Share | 118.17 | 124.25 | 131.5 | 145.08 | 164.58 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 114 | 169 | 82 | 58 | 123 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Medplus Health Services demonstrates strong profitability across various metrics. High gross profit margin, ROCE, ROE, ROA, operating margin, and net margin indicate efficient operations and strong financial performance. This consistent profitability reflects effective strategies and cost management. The company's profitability positions it favorably for future success and market leadership. The company's profitability is a key strength and should be maintained.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 4.08 | 1.84 | 2.33 | 3.88 | 4.7 |
| Return on Capital Employed (ROCE) | 10 | 5 | 7 | 10 | 13 |
| Return on Equity (ROE) | 6.7 | 3.35 | 4.18 | 8.62 | 11.14 |
| Return on Assets (ROA) | 10.52 | 9.51 | 11.81 | 14.52 | 15.43 |
| Operating Margin | 7.22 | 5.84 | 6.31 | 7.95 | 8.81 |
| Net Margin | 2.51 | 1.1 | 1.17 | 2.44 | 3.19 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
Medplus Health Services exhibits mixed efficiency in its operations. While the receivables turnover is exceptionally high, fixed asset and capital turnover are low. Inventory management also needs improvement. Efficient receivables management is a key strength, but operational inefficiencies could hinder overall performance. The company needs to focus on optimizing asset utilization and inventory turnover to enhance its efficiency.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 4.73 | 4.01 | 4.53 | 4.73 | 4.32 |
| Inventory Turnover Ratio | 4.36 | 4.35 | 4.42 | 4.39 | 4.82 |
| Receivables Turnover Ratio | 687.09 | 607.73 | 416.67 | 395.87 | 344.6 |
| Days Sales in Inventory Ratio | 83.72 | 83.91 | 82.58 | 83.14 | 75.73 |
| Receivable Days | 0.53 | 0.6 | 0.88 | 0.92 | 1.06 |
| Capital Turnover Ratio | 1.81 | 1.91 | 2.17 | 2.14 | 2.03 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
Medplus Health Services demonstrates mixed coverage capabilities. The interest coverage ratio suggests an adequate ability to meet interest obligations. However, the equity dividend coverage ratio is low, indicating potential limitations in dividend payouts. Overall, the company's coverage position requires attention to ensure it can comfortably meet its financial obligations and potentially reward shareholders.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 2.79 | 1.57 | 1.76 | 2.78 | 3.29 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
Medplus Health Services demonstrates a stable financial structure with a balanced mix of debt and equity. The debt and debt-to-equity ratios indicate reasonable leverage. The equity ratio reflects a healthy proportion of equity financing. The debt-to-asset ratio suggests efficient asset utilization. Overall, the company's solvency position is robust, providing a solid foundation for future growth and stability.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.32 | 0.38 | 0.39 | 0.39 | 0.42 |
| Debt to Equity Ratio | 0.47 | 0.61 | 0.64 | 0.64 | 0.72 |
| Equity Ratio | 0.68 | 0.62 | 0.61 | 0.61 | 0.58 |
| Debt To Asset Ratio | 0.26 | 0.32 | 0.34 | 0.33 | 0.36 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
Medplus Health Services exhibits a strong ability to meet its short-term obligations. High current and cash ratios indicate ample liquid assets. While the quick ratio is good, the operating cash flow ratio requires attention. The company's liquidity position is a key strength, providing financial flexibility. A high current ratio could also indicate that the company is not efficiently using its current assets, which can be further investigated.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 3.52 | 4.02 | 4.2 | 4.09 | 4.33 |
| Quick Ratio | 1.71 | 1.2 | 0.99 | 1.4 | 1.73 |
| Cash Ratio | 0.07 | 0.7 | 0.34 | 0.73 | 0.87 |
| Operating Cash Flow Ratio | 0.34 | 0.22 | 0.35 | 1.08 | 0.93 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medplus Health Services Ltd | 7.50 | 47.14 | Neutral | 607.00 | 5.20 | 220.00 |
The management of Medplus Health Services demonstrates mixed performance. Revenue growth is consistent, with a 3-year compounded sales growth of 18%. Profit growth shows volatility over the years. Operating Profit Margin and Return on Equity are concerning, indicating potential inefficiencies in capital utilization. The promoter holding is stable. The high PE ratio of 70.2 and a dividend yield of 0.00% may deter some investors. Overall, the company demonstrates growth potential but needs to address profitability and efficiency concerns.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Compounded Sales Growth (3Y) | 18% | Strong revenue expansion |
| Promoter Holding | 40.33% | Confidence and alignment | |
| YOY Profit Growth (Jun'24) | 280% | Very strong profit growth | |
| CONS | P/E Ratio | 70.2 | High valuation |
| Dividend Yield | 0.00% | Inconsistent sharing of profits | |
| ROCE | 1.33% | Capital being used unproductively |
Financial Performance & Growth
Medplus Health Services demonstrates consistent revenue growth, as evidenced by its compounded sales growth. The 3-year compounded sales growth is 18%, indicating a positive trend in revenue expansion. However, the TTM sales growth is 9%, which is lower than the 3-year average. This suggests a recent slowdown in sales growth.
| Metric | 2016-2018 | 2019-2021 | 2022-2024 | 2025 |
|---|---|---|---|---|
| CAGR Sales Growth (%) | 11.35% | 16.12% | 15.81% | 9.09% |
While the company has shown consistent revenue growth over the years, recent performance indicates a need to monitor and potentially address the slowing sales growth to maintain its growth trajectory.
Capital Efficiency & Returns
Medplus Health Services exhibits a concerning trend in its Return on Capital Employed (ROCE). The current ROCE is 1.33%, which is significantly lower than the desired benchmark, indicating inefficient capital utilization. The ROCE has shown fluctuations over the years, with a recent decline.
| Metric | 2016 | 2019 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROCE % | 11% | 12% | 10% | 5% | 7% | 10% |
This declining ROCE trend suggests that the company is facing challenges in generating returns from its capital investments. Effective measures to improve capital efficiency are essential to enhance profitability and investor confidence.
Financial Health & Prudence
Medplus Health Services has seen a consistent increase in borrowings over the years. Total borrowings have risen from ₹ 170 Cr in Mar 2015 to ₹ 1,120 Cr in Mar 2025. This increase in debt may indicate a need for careful monitoring.
| Metric | 2015-2017 | 2018-2020 | 2021-2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Average Borrowings (₹ Cr) | 199 | 361 | 768 | 1,010 | 1,120 |
The rise in borrowings suggests that the company is increasingly relying on debt to finance its operations and expansion. Monitoring the debt levels and ensuring that the company can comfortably service its debt obligations is crucial for maintaining financial stability.
Shareholding & Ownership Structure
The promoter holding in Medplus Health Services is relatively stable, indicating sustained confidence in the company's prospects. The promoter holding has remained consistently around 40% over the last few years.
| Metric | Jun 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding (%) | 40.43% | 40.43% | 40.39% | 40.33% |
A stable promoter holding generally reflects a long-term commitment and alignment of interests between the management and the shareholders. This can be viewed positively by investors, as it signals that the company's leadership has faith in its future performance.
Medplus Health Services demonstrates a moderate risk profile. Revenue growth is consistent, profit growth is volatile and ROCE is low, indicating operational inefficiencies. The increasing debt levels require careful monitoring. The company's Cash Conversion Cycle is lengthening, suggesting potential challenges in working capital management. The shareholding pattern indicates stable promoter holding and increasing FII participation, but decreasing DII interest.
Foreign exchange or interest rate exposure
Medplus Health Services' financial statements provide limited information on specific foreign exchange exposures. However, as a company primarily operating within India, its direct exposure to foreign exchange fluctuations may be limited unless it has significant import or export activities. The company's interest expense is increasing, rising from ₹ 14 Cr in Mar 2015 to ₹ 103 Cr in Mar 2025. Therefore, Medplus Health Services is exposed to interest rate risk.
Regulatory compliance cost trends
The business of Medplus Health Services is subject to various regulatory requirements including licenses and permits and storage norms. Increasing stringent norms implemented by the government may affect business and increase regulatory compliance costs.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 10849.03Bearish
- SMA 20853.97Bearish
- SMA 50864.11Bearish
- EMA 10849.11Bearish
- EMA 20853.57Bearish
- EMA 50860.87Bearish
- DEMA 10844.58Bullish
- DEMA 20846.44Bearish
- DEMA 50851.95Bearish
- TEMA 10844.32Bullish
- TEMA 20843.78Bullish
- TEMA 50850.32Bearish
- MACD-5.48Bearish
- ADX28.31Strong Trend
- IndicatorValueSignal
- RSI32.74Neutral
- CCI-138.78Oversold
- ROC 9-0.98Bearish
- ROC 14-2.05Bearish
- ROC 25-2.36Bearish
- Stoch K20.48Neutral
- Stoch D26.59Neutral
- IndicatorValueSignal
- BB Upper865.62Neutral
- BB Middle853.97Neutral
- BB Lower842.32Neutral
- ATR5.85Low Volatility
- IndicatorValueSignal
- MFI11.34Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10853.35Bearish
- SMA 20861.61Bearish
- SMA 50864.96Bearish
- EMA 10852.92Bearish
- EMA 20858.08Bearish
- EMA 50866.90Bearish
- DEMA 10846.56Bearish
- DEMA 20850.85Bearish
- DEMA 50854.85Bearish
- TEMA 10844.75Bearish
- TEMA 20847.93Bearish
- TEMA 50850.57Bearish
- MACD-5.91Bearish
- ADX21.58Weak Trend
- IndicatorValueSignal
- RSI33.22Neutral
- CCI-128.69Oversold
- ROC 9-1.51Bearish
- ROC 14-2.36Bearish
- ROC 25-2.68Bearish
- Stoch K21.05Neutral
- Stoch D16.90Oversold
- IndicatorValueSignal
- BB Upper881.63Neutral
- BB Middle861.61Neutral
- BB Lower841.59Neutral
- ATR8.90Low Volatility
- IndicatorValueSignal
- MFI35.56Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10859.18Bearish
- SMA 20861.92Bearish
- SMA 50887.04Bearish
- EMA 10856.32Bearish
- EMA 20862.86Bearish
- EMA 50873.33Bearish
- DEMA 10848.94Bearish
- DEMA 20851.98Bearish
- DEMA 50867.13Bearish
- TEMA 10846.01Bearish
- TEMA 20849.93Bearish
- TEMA 50N/AN/A
- MACD-8.22Bearish
- ADX16.10Weak Trend
- IndicatorValueSignal
- RSI37.49Neutral
- CCI-133.18Oversold
- ROC 9-3.13Bearish
- ROC 14-1.46Bearish
- ROC 25-5.41Bearish
- Stoch K8.95Oversold
- Stoch D12.17Oversold
- IndicatorValueSignal
- BB Upper883.47Neutral
- BB Middle861.92Neutral
- BB Lower840.38Neutral
- ATR15.72Low Volatility
- IndicatorValueSignal
- MFI72.48Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10864.20Bearish
- SMA 20879.01Bearish
- SMA 50881.89Bearish
- SMA 100857.46Bearish
- SMA 200829.17Bullish
- EMA 10867.34Bearish
- EMA 20874.24Bearish
- EMA 50873.69Bearish
- EMA 100860.85Bearish
- EMA 200842.93Bullish
- DEMA 10859.12Bearish
- DEMA 20866.14Bearish
- DEMA 50885.18Bearish
- DEMA 100883.72Bearish
- DEMA 200872.74Bearish
- TEMA 10858.12Bearish
- TEMA 20856.87Bearish
- TEMA 50878.92Bearish
- TEMA 100891.53Bearish
- TEMA 200879.27Bearish
- MACD-6.86Bearish
- ADX11.83Weak Trend
- IndicatorValueSignal
- RSI42.04Neutral
- CCI-94.32Neutral
- ROC 14-4.95Bearish
- ROC 25-4.35Bearish
- Stoch K33.33Neutral
- Stoch D41.49Neutral
- IndicatorValueSignal
- BB Upper925.58Neutral
- BB Middle879.01Neutral
- BB Lower832.45Neutral
- ATR28.59Low Volatility
- IndicatorValueSignal
- MFI60.39Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20864.13Bullish
- SMA 50835.77Bullish
- EMA 20865.63Bullish
- EMA 50839.06Bullish
- DEMA 20890.00Bearish
- DEMA 50872.81Bullish
- TEMA 20898.48Bearish
- TEMA 50882.08Bearish
- MACD18.48Bullish
- ADX26.56Strong Trend
- IndicatorValueSignal
- RSI53.77Neutral
- CCI62.76Neutral
- ROC 144.81Bullish
- ROC 257.48Bullish
- Stoch K37.25Neutral
- Stoch D45.40Neutral
- IndicatorValueSignal
- BB Upper927.45Neutral
- BB Middle864.14Neutral
- BB Lower800.82Neutral
- ATR60.29Low Volatility
- IndicatorValueSignal
- MFI62.67Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6843.52Bullish
- SMA 12838.93Bullish
- SMA 24792.94Bullish
- EMA 6854.44Bullish
- EMA 12835.23Bullish
- EMA 24812.74Bullish
- DEMA 6876.59Bullish
- DEMA 12863.96Bullish
- DEMA 24845.05Bullish
- TEMA 6887.33Bullish
- TEMA 12871.30Bullish
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX18.04Weak Trend
- IndicatorValueSignal
- RSI49.52Neutral
- CCI138.62Overbought
- ROC 2528.45Bullish
- ROC 50-11.76Bearish
- Stoch K54.95Neutral
- Stoch D47.46Neutral
- IndicatorValueSignal
- BB Upper962.59Neutral
- BB Middle815.91Neutral
- BB Lower669.22Neutral
- ATR113.33High Volatility
- IndicatorValueSignal
- MFI60.26Neutral